• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


H&T Presspart Low GWP Banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Complementary particle characterization techniques for faster DPI development

Summary

[one_third]


Number of actuations/measurement

Speed of measurement

Metric measured




Regulatory requirement


Primary applications

[/one_third][one_third]

Cascade Impaction

Multiple and variable

2 PSD measurements/hour

Aerodynamic particle size distribution of the API



For all OINDPs


Drug delivery efficiency assessment as part of R&D and for routine QC

[/one_third][one_third]

Laser diffraction

One

10,000 measurements/sec

Volumetric based particle size distribution and concentration for the formulation

For nasal sprays and some nebulized formulations

Understand and aerosolization behavior during R&D, Routine QC for nasal sprays and some nebulisers

[/one_third]

Further reading on the application of laser diffraction in DPI studies:
P.Kippax and D. Morton “Unlocking the secrets of the dry powder inhaler plume” Drug Delivery Technology, Jan 2008, Vol 8, No1

S. R. R. Behara et al. ‘An approach to characterising the cohesive behaviour of powders using a flow titration aerosolisation based methodology’ Chemical Engineering Science 04/2011; 66(8):1640-1648.

For further reading on the application of MDRS in DPI studies:

Component specific particle characterisation of dry powder inhaler formulations

Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.

Share
« Previous Page 1 2 3 4

published on April 7, 2015

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Catalent banner
    © 2025 OINDPnews